Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients

We conducted a feasibility study to investigate the therapeutic effect of bevacizumab on vestibular schwannomas (VS) associated with neurofibromatosis type 2 (NF2) in a sample of Japanese patients. Ten NF2 patients were selected between 2013 and 2018: nine women and one man, with ages ranging from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: FUJII, Masazumi, ICHIKAWA, Masahiro, IWATATE, Kensho, BAKHIT, Mudathir, YAMADA, Masayuki, KUROMI, Yosuke, SATO, Taku, SAKUMA, Jun, SAITO, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040431/
https://www.ncbi.nlm.nih.gov/pubmed/31902875
http://dx.doi.org/10.2176/nmc.oa.2019-0194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040431/
https://www.ncbi.nlm.nih.gov/pubmed/31902875
http://dx.doi.org/10.2176/nmc.oa.2019-0194

Ejemplares similares